sayacare_log

Hey, User !

Select delivery location

Fill in New Patient Details

Welcome to SayaCare- India's only E-pharmacy that Tests every Batch👋FREE delivery on 1st order — Use coupon: TESTME101

sayacare_logosayacare_logo

Lenalidomide 10 mg | Capsule

Lenalidomide 10 mg | Capsule, Pack of 10 capsule

Lenalidomide 10 mg | Capsule

Drug Code: 934

| capsulecapsule| Pack of 10 capsule
MRP ₹464

₹464

Per unit price

₹ 46.4/capsule

Out Of Stock

WHO- GMP

Sourced Medicines

Each Batch Tested

by SayaCare at Govt. Certified NABL

1,00,000+

Trusted customers

Batch Details

Composition

lenalidomide 10 mg

Batch

NC0025D

Expiry

August 2022

Brands with same SaltBut mostly higher prices

lenalidomide

₹ 8976

lenzest 10mg capsule

₹ 2888

lenome 10 capsule

₹ 1691

lenalimide 10 mg capsule

₹ 949

lenalid

₹ 8800

lenid 10mg capsule

₹ 2900

lenmid 10 capsule

₹ 999

lenagio

₹ 1013

lenangio 10 capsule

₹ 1013

myelosafe capsule

₹ 98

Why Choose SayaCare ?

You pay for the medicine, not the brand name

Same active ingredients

Exact Same Dosage Type

Lab Tested Quality

Transparent Test Report

Batch Details

Composition

lenalidomide 10 mg

Batch

NC0025D

Expiry

August 2022

India's OnlyE- Pharmacy
That Tests Every Medicine Batch.

Tested hai, Toh bharosa hai!

Safe medicines

-Rigorously Tested-

Quality Reports

-Full Transparency-

Low Prices

-Save up to 80%-

Home Delivery

-Fast & Reliable-

Disclaimer

All brand names, trademarks, trade dress, logos, and product names of third parties appearing on SayaCare are the property of their respective owners and are protected under applicable intellectual property laws, including the Trade Marks Act, 1999. SayaCare claims no ownership over, or association with, any such third-party intellectual property.

Third-party brand names and trademarks are referenced on this platform for the purposes of product identification and to assist users in locating generic or equivalent alternatives, in accordance with honest commercial practices under the Trade Marks Act, 1999. Such references do not form part of SayaCare's own branding or promotional identity.

SayaCare is an independent platform and is not affiliated with, endorsed by, sponsored by, or acting as an authorised agent or distributor of any brand referenced herein, and makes no such representation to consumers. The appearance of any brand name on this platform does not imply any formal partnership, endorsement, or direct commercial relationship with the respective brand owner.

Where SayaCare provides information on the generic equivalence of any product to a branded medicine, such information is based on publicly available regulatory data, including schedules under the Drugs and Cosmetics Act, 1940, and information published by the CDSCO. Any editorial content, ratings, or commentary represents the independent views of the platform and should not be attributed to any third-party brand. Neither should be construed as a statement regarding a brand's overall performance or reputation.

All information on this platform is for general awareness only and does not constitute medical advice. Users are strongly advised to consult a registered medical practitioner or licensed pharmacist before substituting any branded medicine with a generic alternative or acting on any information available here. SayaCare is not responsible for brand references or opinions expressed by users in reviews or uploaded content, which represent the views of individual users alone. Users are prohibited from uploading content that infringes the intellectual property rights of any third party.

SayaCare respects the intellectual property rights of all brand owners and does not intend to infringe upon any trademark, trade dress, or related right. If you believe any content on this platform infringes your rights, please contact our IP Grievance Officer at [email protected] . All bona fide complaints will be reviewed within 7 business days and appropriate remedial action taken where infringement is established. This mechanism is maintained in accordance with the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Rules, 2021.